A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after the successful development of a new alpha-ray therapeutic...
A recent British Journal of Cancer evaluated the real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer (mTNBC). Study: Real world study of sacituzumab govitecan...
In a recent study published in the journal The Lancet Digital Health, scientists in the United States evaluated the efficacy and challenges of artificial intelligence (AI) in...